Back
Axsome Therapeutics Vs. Repligen Industry Stock Comparison
Buy
61
AXSM
Axsome Therapeutics
Last Price:
98.18
Seasonality Move:
43.77%
Sell
45
RGEN
Repligen
Last Price:
141.70
Seasonality Move:
11.98%
Buy
61
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $94.60. The Score for AXSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $138.90. The Score for RGEN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $94.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 55.46 | Buy |
| Chaikin Money Flow: | -272803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.79 - 94.85) | Buy |
| Bollinger Bands (100): | (84.18 - 92.58) | Buy |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.98 | Sell |
| Relative Strength Index (14 RSI): | 50.12 | Buy |
| Chaikin Money Flow: | 770495 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.33 - 146.11) | Sell |
| Bollinger Bands (100): | (130.18 - 153.68) | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.17 | Sell |
| 20-day SMA: | 91.8 | Buy |
| 50-day SMA: | 90.71 | Buy |
| 200-day SMA: | 82.6 | Buy |
| 8-day EMA: | 94.2 | Buy |
| 20-day EMA: | 92.6 | Buy |
| 50-day EMA: | 90.65 | Buy |
| 200-day EMA: | 83.93 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.06 | Buy |
| 20-day SMA: | 138.23 | Buy |
| 50-day SMA: | 140.24 | Sell |
| 200-day SMA: | 156.61 | Sell |
| 8-day EMA: | 135.39 | Buy |
| 20-day EMA: | 138.01 | Buy |
| 50-day EMA: | 140.44 | Sell |
| 200-day EMA: | 150.68 | Sell |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and an increase next year of $3.91 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
Axsome Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||